ESR1 and prostate carcinoma: The alteration of ACSL4 expression is essential in the development and progression of breast and prostate cancers: ER expression is inversely correlated with ACSL4 expression in breast cancer (84), and ACSL4 is also involved in the loss of steroid hormone sensitivity and the acquisition of castration resistance in prostate cancer (85, 88).